Caribou Biosciences annual total assets
2020
2021
2022
2023
2024
2025
Caribou Biosciences Total Assets Growth & History (CRBU)
Caribou Biosciences's total assets was $175.4M for fiscal 2025.
View full Caribou Biosciences company overviewCaribou Biosciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $175.4M | −$137.9M | −44.03% |
| 2024 | 2024-12-31 | $313.3M | −$118.9M | −27.51% |
| 2023 | 2023-12-31 | $432.2M | $58.4M | +15.64% |
| 2022 | 2022-12-31 | $373.8M | −$68.6M | −15.51% |
| 2021 | 2021-12-31 | $442.4M | $406.3M | +1127.20% |
| 2020 | 2020-12-31 | $36.0M | — | — |
Caribou Biosciences quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $142.8M | −$78.1M | −35.37% |
| Q1 2026 | 2026-03-31 | $149.0M | −$124.7M | −45.55% |
| Q4 2025 | 2025-12-31 | $175.4M | −$137.9M | −44.03% |
| Q3 2025 | 2025-09-30 | $195.0M | −$149.3M | −43.37% |
| Q2 2025 | 2025-06-30 | $220.9M | −$152.0M | −40.77% |
| Q1 2025 | 2025-03-31 | $273.7M | −$133.2M | −32.73% |
| Q4 2024 | 2024-12-31 | $313.3M | −$118.9M | −27.51% |
| Q3 2024 | 2024-09-30 | $344.3M | −$113.2M | −24.74% |
| Q2 2024 | 2024-06-30 | $372.9M | $23.3M | +6.66% |
| Q1 2024 | 2024-03-31 | $406.8M | $59.4M | +17.08% |
| Q4 2023 | 2023-12-31 | $432.2M | $58.4M | +15.64% |
| Q3 2023 | 2023-09-30 | $457.5M | $58.7M | +14.72% |
| Q2 2023 | 2023-06-30 | $349.6M | −$71.7M | −17.02% |
| Q1 2023 | 2023-03-31 | $347.5M | −$98.5M | −22.09% |
| Q4 2022 | 2022-12-31 | $373.8M | −$68.6M | −15.51% |
| Q3 2022 | 2022-09-30 | $398.8M | −$63.1M | −13.67% |
| Q2 2022 | 2022-06-30 | $421.4M | $263.0M | +166.02% |
| Q1 2022 | 2022-03-31 | $446.0M | — | — |
| Q4 2021 | 2021-12-31 | $442.4M | $406.3M | +1127.20% |
| Q3 2021 | 2021-09-30 | $462.0M | — | — |
| Q2 2021 | 2021-06-30 | $158.4M | — | — |
| Q4 2020 | 2020-12-31 | $36.0M | — | — |
Caribou Biosciences total assets trends
Over the last five fiscal years, Caribou Biosciences's total assets increased from $36.0M to $175.4M, a change of $139.3M. The latest reported quarter, Q2 2026, shows $142.8M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Caribou Biosciences source filings ↗